One-year safety and effectiveness of insulin degludec in patients with diabetes mellitus in routine clinical practice in India—TRUST (Tresiba real-world use study)

One-year safety and effectiveness of insulin degludec in patients with diabetes mellitus in routine clinical practice in India—TRUST (Tresiba real-world use study)

Objective: This post-authorization safety study (PASS) was conducted to evaluate the long-term safety and effectiveness of insulin degludec in patients with diabetes mellitus (DM) requiring insulin therapy in routine clinical practice in India. Methods: Data on glycated hemoglobin (HbA1c) and advers...

Full description

Bibliographic Details
Main Authors: Jothydev Kesavadev, L.Sreenivasa Murthy, Tirthankar Chaudhury, Sadasiva Rao Yalamanchi, J. Giri, Sunil Gupta, Sanjeev Phatak, K.D. Modi, Sanjay Chatterjee, Aparna Manjunath, Manjunatha Revanna, Arpandev Bhattacharya
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Metabolism Open
Subjects:
Insulin degludec
Diabetes mellitus
Safety
Post-authorization safety study
Effectiveness
Real-world evidence
Online Access:http://www.sciencedirect.com/science/article/pii/S2589936822000226

Internet

http://www.sciencedirect.com/science/article/pii/S2589936822000226

Similar Items